Cello Therapeutics is Biotechnology in United States that focus on immunomodulatory agents business. Founded in 2016. They cover business area such as operator, biomimetic cell membrane-coat nanoparticle, cancer drug delivery, three main component, namely chemotherapy, agent, biocompatible polymer, human cell, therapeutic company, novel and effective medical treatment, cancer patient.
2016
( 8 years old in 2024 )
Immunomodulatory Agents
-
5945 Pacific Center Boulevard
Suite 507
San Diego, CA 92121
United States
Private
operatorbiomimetic cell membrane-coat nanoparticlecancer drug deliverythree main componentnamely chemotherapyagentbiocompatible polymerhuman celltherapeutic companynovel and effective medical treatmentcancer patient
* We use standard office opening hours in near Cello Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cello Therapeutics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Cello Therapeutics business is focusing on Immunomodulatory Agents.
Cello Therapeutics headquarter office and corporate office address is located in 5945 Pacific Center Boulevard Suite 507 San Diego, CA 92121 United States.
Cello Therapeutics was founded in United States.
In 2024, Cello Therapeutics is currently focus on immunomodulatory agents sector.
Above is snippet of Google Trends for "immunomodulatory agents" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cello Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
